Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1998; 79(04): 876-877
DOI: 10.1055/s-0037-1615082
DOI: 10.1055/s-0037-1615082
Letters to the Editor
Expression of the Factor VII Activating Protease, Hepsin, in situ in Renal Cell Carcinoma
Authors
Further Information
Publication History
Received
01 May 1997
Accepted after resubmission
21 November 1997
Publication Date:
07 December 2017 (online)
-
References
- 1 Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Sem Thromb Hemost 1992; 18: 104-16.
- 2 Costantini V, Zacharski LR. Fibrin and cancer. Thromb Haemost 1993; 69: 406-14.
- 3 Zacharski LR, Dunwiddie C, Nutt EM, Hunt J, Memoli VA. Cellular localization of activated factor X by a Xa-specific probe. Thromb Haemost 1991; 65: 545-48.
- 4 Zacharski LR, Morain WD, Schlaeppi J-M, Memoli VA, Rousseau SM. Cellular localization of enzymatically active thrombin in intact human tissue by hirudin binding. Thromb Haemost 1995; 73: 793-7.
- 5 Zacharski LR, Memoli VA, Rousseau SM. Cancer-coagulation interaction in situ in renal cell carcinoma. Blood 1986; 68: 394-9.
- 6 Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM, Stump DC. Fibrinogen-fibrin transformation in situ in renal cell carcinoma. Anticancer Research 1990; 10: 579-582.
- 7 Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SA, Stump DC. Malignant melanoma: interaction with coagulation and fibrinolysis pathways in situ . Am J Clin Pathol 1990; 93: 516-21.
- 8 Zacharski LR, Ornstein DL, Memoli VA, Kisiel W, Rousseau SM. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Nat’l Cancer Inst 1993; 85: 1225-30.
- 9 Leytus SP, Loeb KR, Hagen FS, Kurachi K, Davie EW. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochem 1988; 27: 1067-74.
- 10 Kurachi K, Torres-Rosado A, Tsuji A. Hepsin. Methods Enzymol 1994; 244: 100-14.
- 11 Tsuji A, Torres-Rosado A, Arai T, Chou SH, Kurachi K. Characterization of hepsin, a membrane bound protease. Biomed biochim acta 1991; 50: 791-3.
- 12 Tsuji A, Torres-Rosado A, Arai T, Lebeau MM, Lemons RS, Chou SH, Kurachi K. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem 1991; 266: 16 948-53.
- 13 Kazama Y, Hamamoto T, Foster DC, Kisiel W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 1995; 270: 66-72.
- 14 Torres-Rosado A, O’Shea KS, Tsuji A, Chou SH, Kurachi K. Hepsin, a putative cell- surface serine protease, is required for mammalian cell growth. Proc Nat’l Acad Sci 1993; 90: 7181-5.
- 15 Zacharski LR, Donati MB, Rickles FR. Registry of clinical trials of antithrombotic drugs in cancer: second report. Thromb Haemost 1993; 70: 357-60.
- 16 Lebeau B, Chastang C, Brechot J-M, Capron F, Dautzenberg B, Delaisements C, Mornet M, Brun J, Hurdebourcq J-P, Lemarie E. Subcutaneous heparin treatment increases survival in small cell lung cancer. Cancer 1994; 74: 38-45.